🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Rhabdomyosarcoma, Child

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma NCT04625907Phase 1, Phase 2128 sites📍 Brisbane📍 Camperdown📍 Clayton University of Birmingham · Tests: Irinotecan, Actinomycin D, Doxorubicin, Ifosfamide, Vincristine Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease NCT06023641Phase 23 sites📍 Palo Alto📍 Memphis📍 Fort Worth St. Jude Children's Research Hospital · Tests: Vincristine, Dactinomycin, Cyclophosphamide, Surgical Resection, Proton beam radiation or external beam radiation or br… Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents NCT06816771Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: pazopanib, TGI chemotherapy, CIV chemotherapy Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling NCT05857969Phase 11 site📍 Miami Florida International University · Tests: Functional Precision Medicine PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors NCT06721689Phase 1, Phase 27 sites📍 Los Angeles📍 San Francisco📍 Boston Theodore Laetsch · Tests: PEEL-224, Vincristine, Temozolomide (TMZ) FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma NCT06865664Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: fludarabine, cyclophosphamide, cetuximab, FGFR4-CAR T Cells Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study NCT05457829Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine Preliminary Clinical Study of Entinostat in Children With Malignant Soft Tissue Sarcoma Harboring PAX-family Gene Abnormalities NCT07888114Phase 11 site📍 Beijing Beijing Tongren Hospital · Tests: Entinostat, VAC/VTC chemotherapy Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas NCT07222735Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells, Radiation Therapy Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites📍 Palo Alto📍 Aurora📍 Washington D.C. St. Jude Children's Research Hospital · Tests: Onivyde, Talazoparib, Temozolomide Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen NCT06456892Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Pucotenlimab Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies NCT04308330Phase 11 site📍 Valhalla New York Medical College · Tests: Vorinostat Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors NCT04715191Phase 11 site📍 Houston Baylor College of Medicine · Tests: CARE T cells Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors NCT06541262Phase 1, Phase 224 sites📍 Birmingham📍 Phoenix📍 Oakland Milton S. Hershey Medical Center · Tests: Silmitasertib, Irinotecan, Temozolomide, Vincristine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy